ASX Release 30 April 2022

AHI Progresses Further Agreements with Key Partners

For personal use only

Advanced Human Imaging Ltd (ASX: AHI) (NASDAQ: AHI) ('AHI' or 'the Company') is pleased to release its Appendix 4C and to provide its shareholders with an update on its activities for the quarter ended 31 March 2022.

HIGHLIGHTS

  • AHI signs a binding term sheet with Activate Health.

  • AHI signs a binding term sheet with Vertica Health.

  • AHI concluded definitive agreements with Inter-Psy.

  • Bearn launched the iOS AHI integration into the Appstore.

  • AHI concluded definitive agreements with Nextmedicall S.A.C.

  • AHI concluded definitive agreements with Singapore based BizBaz.

  • AHI concluded definitive agreements with Vertica Health.

  • Tinjoy's "The Health Cube" application has launched across multiple Android stores in China, further progress hampered by China's zero-Covid strategy.

  • The integration of AHI's CompleteScan technology into the Nexus-Vita application is progressing and completion is targeted for May 2022.

  • Dr Katherine Iscoe, co-founder of AHI, was appointed as Chief Executive Officer and Executive Director of the Company in mid-February 2022, following the resignation of Mr Vlado Bosanac from both the Board and the position of CEO on 14 February 2022. Mr Bosanac has been appointed as Strategy and Revenue Lead for the Company.

  • Mr Simon Durack JP was appointed Company Secretary and CFO in mid-March 2022, following the resignation of Mr Steven Richards.

ASX Code: AHI

ABN 85 602 111 115

Non-Executive Directors Nick Prosser - Chairman Mike Melby

Unit 5, 71-73 South Perth Esplanade, South Perth, WA 6151

Dato Low Koon Poh Edward F. Greissing Jr

PO Box 190

Issued Capital: ~162.5M

Options Issued: ~5.8M

Perform Rights: ~17.1M

Executive Director, CEO Dr Katherine Iscoe

Share price: $0.30 (31 March 2022)

South Perth, WA 6951 investors@ahi.tech www.ahi.tech

Company Secretary, CFO

Simon Durack JP

Advanced Human Imaging Ltd, ACN 602 111 115

PO Box 190, South Perth WA 6951

investors@ahi.tech

Vlado Bosanac, Strategy and Revenue Lead said:

For personal use only

"The Company continued to make strong commercial progress this quarter with the signing of multiple term sheets and definitive agreements. AHI is currently assisting multiple partners with the integration of the BodyScan and FaceScan capabilities. Additionally, AHI is pleased to note that the digital health market as a whole is incredibly active and with this comes a great deal of interest in the personalised data the AHI scans deliver.

As many investors are no doubt aware, the AHI share price has been under significant pressure over the past few months, with the new strains of COVID 19 and the unsettling war in the Ukraine, which has affected the market as a whole and AHI has unfortunately been affected like many other listed companies. In a global market characterised by both uncertainty and a certain pandemic, there are many challenges to overcome, not only for AHI but for many other businesses around the globe including but not limited to many of our partners that have unexpected delays. AHI will continue to do all things the Company can to assist them in going live and driving engagement into its combined technologies.

AHI remains focused on executing its plans, to grow awareness and partnerships across the globe. AHI has a good cash balance that it expects to further bolster as it nears its revenue goals via both its current and near-term partner releases. There are challenges which AHI must face which it will overcome in due course as the world is beginning to open up allowing the Company's partners to access critical skill and funding that has been more difficult through these times. The harsh reality is that certain projects have simply taken longer to complete in the current climate. Importantly all of AHI's partners remain firmly in place and the Company is assisting them where possible.

AHI's strategic objectives, the quality of its technology and the Company's potential has not changed. AHI has an incredibly strong foundation from which it will launch this next phase of its growth plans".

AHI COMPLETED SEVERAL BINDING TERM SHEETS

Over the course of Q1 2022, AHI was active in the execution of binding term sheets with South Africa based Vertica Health and Activate Health OU.

About Vertica Health

Vertica is a digital health company that builds and provides innovative health risk solutions for downstream customers. The team includes highly specialised and experienced scientists in medicine and engineering. Vertica has targeted Insurance and Occupational Safety markets and has recently expanded into retail insurers, medical aids, global re-insurers and the mining industry. Vertica is in advanced stages with a number of these organisations to integrate the Vertica Solution and market-ready designs with target launches during the second half of 2022 and into 2023. Vertica is planning to conclude the integration of the AHI CompleteScan SDK in Q2 2022 into their solution suite.

About Activate Health OÜ

Activate Health OÜ ("Activate") is a digital health company born in the pandemic on a mission to radically extend the human health span and make 100 healthy years the new normal. Activate believes that people have an untapped potential to live a longer life in good health, be active and perform at their best every single day. Activate was founded to help people achieve their untapped potential. Activate helps people wake up every morning feeling fully rested and ready to tackle any task with constant energy. What if their body and brain performed at their highest level throughout the day? What if people slept better and recovered faster, felt less anxiety and more happiness? And what if all that lasted a decade or two longer than today's statistics would predict? Activate believes that this future is within people's grasp and accessible to everyone if they took control of their own brains and body. People make hundreds of inter-connected choices each day that impact their physical and mental health. When people eat cleaner, they have more energy to be active, leading to better sleep at night, which results in a better mood and focus the next day. Science shows that by making

Advanced Human Imaging Ltd, ACN 602 111 115

PO Box 190, South Perth WA 6951

investors@ahi.tech

small conscious changes in daily behaviour, physical and mental fitness can climb to a whole new level in just a few months. Activate is here to help people turn this into action. Their platform features medical-grade health audits, targeted micro-programs, and science-backed recommendations.

For personal use only

AHI CONCLUDED MULTIPLE DEFINITIVE AGREEMENTS

Throughout the course of Q1 2022, AHI concluded definitive agreements with several of its partners. These agreements set out the legal obligations the parties have with AHI, commercially, and with regards to the integration, privacy requirements and launch timing. The following parties executed the definitive agreements.

About Inter-Psy

Inter-Psy offers psychological help in the form of diagnostics, counselling and treatment to infants, children, adults and the elderly, whereby promoting mental health through personal, professional contact and evidence-based treatment is paramount. With several locations across the Netherlands in the provinces of Groningen, Friesland and Drenthe and the possibility to receive support in the home situation via Inter-Psy Home, Inter-Psy always offers help close to the patient. Treatments within Inter-Psy are reimbursed from basic health insurance of all health insurers.

About Nextmedicall S.A.C

Nextmedicall is a Peruvian medical and technology company pioneering in telemedicine focusing on chronic disease patients in Latin America, supplying a digital ecosystem that connects healthcare stakeholders, to improve the quality of life of patients at home and abroad. Nextmedicall has an extensive network of doctors and specialists spanning, Traumatology, Orthopaedics, Oncology, Gastroenterology Rehabilitation, Neurosurgery, Gynaecology, Obstetrics, Psychiatry, Dermatology, Paediatrics, Nutrition, and Ophthalmology, specializing in remote personal care. Assisting individuals to locate and connect with specialists in the locality when requiring care or assessment of care. Nextmedicall is an end-to-end care solution providing services across telemedical consultations, prescriptions, treatments, pharmaceutical delivery, laboratory analysis, and online or at-home nursing care. With the integration of the AHI solution, Nextmedicall hopes to provide the solution across Latin America to assist in more affordable care.

About Bizbaz

Bizbaz offers financial intelligence solutions to financial institutions, fintech and e-commerce companies in Asia, including comprehensive consumer and SME profiling and prescoring solutions, which enable them to engage the unbanked and underserved populations and organizations in Asia. Bizbaz products are built considering glades research and cutting-edge insight from behavioural sciences and leverage neural networks and other ML methodologies when collecting, analysing, and extracting insights. With teams in Singapore, Israel, Vietnam, Philippines and Malaysia, Bizbaz offers a full suite of data-driven health and financial intelligence solutions, including but not limited to, comprehensive health and financial risk assessments, alternative credit scoring, fraud detection, eKYC, financial product aggregation and recommendation systems.

In addition, AHI also concluded the definitive agreements with Vertica Health, about Vertica Health, as outlined above.

UPDATE ON PRODUCT LAUNCHES

AHI is currently working with a number of its announced partners and assisting them with their requirements in meeting the integration and launch timelines, the current status of these companies are as follows.

Tinjoy has experienced rolling lockdowns due to the zero-COVID-tolerance policy enforcement throughout China. This has meant the call centre has not been operating throughout the quarter, which is the driving force behind the application's marketing to the previously reported pre-registrations. To date, Tinjoy has had over

Advanced Human Imaging Ltd, ACN 602 111 115

PO Box 190, South Perth WA 6951

investors@ahi.tech

For personal use only

218,000 downloads of the Health Cube application, which has the AHI technology integrated in both iOS and Android platforms. Tinjoy has maintained communications throughout this difficult period in regard to their commitment to the partnership and commencing a significant marketing campaign once restrictions are lifted and they return to their office and call centre. AHI views Tinjoy as a committed partner and will continue to support them and any requirements requested to make this partnership a success.

Communication received from Russell Bateman COO of Tinjoy stated:

"Despite what is a virtual shut down of our ability to run a business in China thanks to Covid restrictions we have some very positive developments.

The health cube (called Jiankang Mofan in Chinese which means, "healthy cube") app now has more than 218,000 active installs as of the end of March 2022. That is all achieved through the referral model. I am unable to get the most recent and accurate figures because of the combined holiday and lockdowns! I will update AHI as soon I can get the most current information.

The latest billing from AHI shows 166 Annual subscriptions and 50 monthly subscriptions. I also believe that we have some 2000+ single scan purchases, that probably aren't in the billing cycle yet.

This is notable because our sales facility is basically offline with staff unable to work in the office or call centre at this time. This is just people finding the scan on the platform and choosing to buy it or exchange the points they have earned for it".

The integration of AHI's CompleteScan technology into the Nexus-Vita application is progressing and AHI has already completed 2 of the 3 phase build and launch program needed to hand over the completed application. As previously outlined, the scope of the project was far more complex than previously anticipated. The additional scope and work required, saw AHI bring in Blue Sky Lab to develop the framework and platform in readiness for the full build and integration of the AHI technology, with both parties having committed all available resources to accelerate the development of the application. At this time, AHI expect to meet the deliver timetable to Nexus Vita by the end of May.

As announced to the ASX on 18 March 2022, Bearn, a Californian-based wellness technology company, have completed the integration of the AHI technology and have launched on both iOS and Android stores. AHI is also pleased to confirm that Bearn has also completed the integration of the FaceScan in both iOS and Android which are now available on the app stores. AHI looks forward to updating shareholders on these additional actions in the near future.

UPDATE ON PRODUCT INTEGRATIONS

AHI announced on 1 December 2021 that it had concluded all definitive agreements with Toronto-based Digital Health provider Cubert Inc who has developed FitTrack My Health ("FitTrack"), a preventative health screening app. Cubert is planning to integrate AHI's technology into the FitTrack app. At this time Cubert have experienced delays in their integration timelines and AHI will continue to work with them as needed to meet their obligations to Cubert for successful integration and launch.

As previously announced to the ASX, AHI signed definitive agreements with NextMedicall. Inter-Psy, Vertica and BizBaz. AHI is pleased to report these companies are in advanced stages of scope and integration. AHI hopes to bring further news to its shareholders throughout Q2, 2022, around timing and go-lives.

Advanced Human Imaging Ltd, ACN 602 111 115

PO Box 190, South Perth WA 6951

investors@ahi.tech

CASHFLOW UPDATE

As at 31 March 2022, AHI had $7.833 million cash at Bank, as detailed in the attached Appendix 4C.

For personal use only

The reported net cash used in operating activities for the quarter ended 31 March 2022 was $3.247 million as reported at item 1.9 in the attached Appewndix 4C. Based on that level of expenditure repeating itself in future quarters, the estimated quarters of funding available is calculated at 2.41 times.

However, this measure of available funding is not regarded as a particularly reliable measure as it assumes that past levels of operating expenditure will be repeated quarter on quarter. In addition to this unreliable assumption, it takes no account of the extraordinary expenditure in the reported quarter that will not be repeated in future quarters.

For example in the quarter ended 31 March 2022, the following extraordinary operating expenditure that is not expected to be repeated in future quarters was identified by AHI:

Extraordinary operating expenditure in the March 2022 quarter not expected to be repeated in future quarters:

Legal fees

$55,000

Share registry costs

$50,000

IT expenses

$11,000

Domestic travel and accommodation expenses

$5,000

International travel and accommodation expenses

$85,000

Unrealised foreign exchange movement

$188,653

Total Extraordinary Operating Expenditure

$309,653 Note 1

On the assumption that the identified extraordinary operating expenditure above will not be reported in future quarters the funding available measure at item 8.5 would increase from 2.41 times to 2.77 times, which is a material improvement on the reported estimated figure.

1The adjusted March 2022 quarter figures produced in this calculation have been produced for illustrative and commentary purposes only.

Cash flow from investing activities:

During the quarter, AHI made a final cash payment to Triage. Under the terms of the Triage Agreement, AHI will invest a total of up to US$6 million into Triage, being US$3 million in cash and US$3 million in equity.

Cash flow from financing activities:

No cash flow financing activity was reported for the quarter ended 31 March 2022 following AHI's recent successful listing on NASDAQ.

Simon Durack, Compant Secretary and CFO of AHI said:

"It has been a productive and challenging quarter in my new role as Company Secretary and CFO at AHI. The team and management are well positioned to make the Company a great success. AHI has a good cash position and from what I am seeing and learning in my new role is that AHI has built an extremely well thought out technology offering that is well poised for the changes and challenges that global healthcare has been subjected to over the past few years, due to COVID 19 and the heavily burdened healthcare systems around the world.

It has been a productive quarter on the commercial front with the signing of new partners and the conclusion of definitive agreements. All of these actions are expected to contribute to AHI's future revenue streams. AHI

Advanced Human Imaging Ltd, ACN 602 111 115

PO Box 190, South Perth WA 6951

investors@ahi.tech

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Advanced Human Imaging Ltd. published this content on 01 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 May 2022 23:26:02 UTC.